# A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia

> **NCT00044044** · PHASE2 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 356 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Lurasidone 20 mg
- **DRUG:** Lurasidone 40mg
- **DRUG:** Lurasidone 80 mg
- **DRUG:** Haloperidol 10mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00044044
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2003-05
- **Final completion:** 2003-05
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2014-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00044044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00044044, "A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00044044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*